Michael Egholm - 04 Apr 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: President & CEO, Director
Signature: /s/ Michael Egholm
Issuer symbol: LAB
Transactions as of: 04 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Apr 2023, 19:02:50 UTC
Previous filing: 21 Jun 2022
Next filing: 05 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Options Exercise	$0	+196,512	+1965%	$0.000000	206,512	04 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LAB	Restricted Stock Units	Options Exercise	$0	-196,512	-25%	$0.000000	589,537	04 Apr 2023	Common Stock	196,512		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 5,000 shares of Common Stock purchased pursuant to Fluidigm Corporation (currently Standard BioTools Inc.) 2017 Employee Stock Purchase Plan ("ESPP") for the purchase period of June 1, 2022 to November 30, 2022.
F2	Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F3	Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.